Case Study:
Using Large Language Models (LLMs) like ChatGPT to Speed Up Medical Literature Monitoring and Insights
How Large Language Models are helping medical affairs teams increase productivity and reduce medical literature monitoring time
The fastest growing bodies of content—in both volume and complexity—are in life sciences and healthcare. Analyzing this content (including clinical studies, publications, guidelines and more) and for medical insights will drive better decisions.
The Client
The client was spending significant time keeping up to date with monitoring and evaluating new medical content. This was a very resource-intense activity and they wanted a way to automate part of this.
The Solution
Using data-driven Natural Language Intelligence (including LLMs) to combine scale and flexibility with contextual understanding, and precision to provide content intelligence for deeper understanding and efficiency.
The Outcome
- Significant Increase in productivity (average from client estimate following implementation is 1000%)
- Significant decrease in literature monitoring time (average from client estimate following implementation is 82-92%)
- Vastly improved tracking to support portfolio products
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.

We’re Doing AI” Is Not a Board Answer
There is a moment I have seen play out in pharmaceutical boardrooms again and again. It usually comes in the second half of the agenda,

Why Most AI Governance Frameworks Are the Wrong Fit for Pharma
Most pharmaceutical organizations now have some form of AI governance. On paper, that sounds reassuring. In practice, it often means a policy document, a review

Why Most Pharma AI Strategies Fail the CFO Test
Most pharmaceutical organizations do not struggle to explain what their AI programmes do. They struggle to explain, in financial terms, why those programmes deserve sustained